Develop effective malaria vaccines that induce long-lasting protection using mRNA technology.
Professor James Beeson and his team are leading next-generation vaccine development for malaria by designing and engineering mRNA vaccines to contain specific proteins of malaria to generate antibodies that can provide highly protective immunity against malaria. The project aims to develop vaccines for Plasmodium falciparum and Plasmodium vivax, which are the two major causes of malaria. Additionally, the is identifying approaches that can generate a long-lasting protective immune response against malaria.
An effective vaccine will alleviate the disease burden in communities globally, especially in low-middle-income settings where the malaria is the highest and where access to resources and health care can be severely constrained.
- mRNA Victoria (Victorian Department of Jobs, Skills, Industry, and Regions)
- Monash Institute of Pharmaceutical Sciences (led by Prof Colin Pouton)
Meet the project team. Together, we are translating research into better health, for all.
Professor Heidi Drummer
SCIENTIFIC DIRECTOR FOR RESEARCH TRANSLATION (SDRT); SCIENTIFIC DIRECTOR, BURNET DIAGNOSTICS INITIATIVE; PRINCIPAL INVESTIGATOR, BURNET VACCINE INITIATIVE; CO-HEAD, VIRAL ENTRY AND VACCINES GROUP
Professor Heidi Drummer is Scientific Director for Research Translation (SDRT) and co-Head of the Vi...